Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission-Reference-Cited by-同舟云学术

Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission

Published:2019-08-20 Issue:7 Volume:322 Page:622
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Flint Alastair J.¹²,Meyers Barnett S.³,Rothschild Anthony J.⁴,Whyte Ellen M.⁵,Alexopoulos George S.³,Rudorfer Matthew V.⁶,Marino Patricia³,Banerjee Samprit⁷,Pollari Cristina D.³,Wu Yiyuan⁷,Voineskos Aristotle N.¹⁸,Mulsant Benoit H.¹⁸,

Affiliation:

1. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

2. Centre for Mental Health, University Health Network, Toronto, Ontario, Canada

3. Department of Psychiatry, Weill Medical College of Cornell University and New York Presbyterian Hospital, Westchester Division, New York

4. University of Massachusetts Medical School and UMass Memorial Health Care, Worcester

5. Western Psychiatric Institute and Clinic, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

6. National Institute of Mental Health, Bethesda, Maryland

7. Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, New York

8. Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/article-pdf/322/7/622/17807943/jama_flint_2019_oi_190079.pdf

Reference35 articles.

1. Challenges in the treatment of major depressive disorder with psychotic features.;Rothschild;Schizophr Bull,2013

2. Psychotic (delusional) depression and completed suicide: a systematic review and meta-analysis.;Gournellis;Ann Gen Psychiatry,2018

3. Are antipsychotics or antidepressants needed for psychotic depression? a systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.;Farahani;J Clin Psychiatry,2012

4. Pharmacological treatment for psychotic depression.;Wijkstra;Cochrane Database Syst Rev,2015

5. Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials.;Deshauer;CMAJ,2008

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Attrition During Acute Pharmacotherapy of Psychotic Depression in a Clinical Trial;Psychiatry Research;2024-09

2. Identification of Pyroptosis-Related Molecular Subtypes and Diagnostic Model development in Major Depressive Disorder;Molecular Biotechnology;2024-08-23

3. Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2);Journal of Psychiatric Research;2024-08

4. Real‐world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment of psychotic depression. Evidence from within‐subject analyses of two nationwide cohorts;World Psychiatry;2024-05-10

5. Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic features;Molecular Psychiatry;2024-03-19